Concept

PCC Transitions

Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports / Changes over Time (PCC cohort 2021 until 2024)

"Of the 609 participants with PCC in 2021, 354 (58.1%) were successfully followed up in 2024.\n\nFigure 2 shows the transitions between PCC and recovery status over time. Most participants (274 [77.4%]) continued to meet criteria for PCC, whereas 80 (22.6%) had fully recovered. By 2024, 59 subjects had newly developed PCC. In total, 333 participants met PCC criteria, of whom 274 (82.3%) had persistent and 59 (17.7%) new-onset PCC.\n\nFig. 2\n\n![Fig. 2](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-026-72491-1/MediaObjects/41598_2026_72491_Fig2_HTML.png)\n\nTransitions in post-COVID-19 condition (PCC) status between the first (July–August 2021) and second (March–September 2024) follow-up surveys. PCC, post-COVID-19 condition. Transitions in post–COVID-19 condition (PCC) status between the first follow-up survey (July–August 2021) and the second follow-up survey (March–September 2024), illustrating persistent PCC, new-onset PCC, recovery, and loss to follow-up. Participants categorized as “Lost to follow-up” did not complete the second follow-up survey."

Related Ideas

  • Persistent PCCFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Factors associated with persistent PCC (2021–2024)
  • Functional LimitationFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Definition of post-COVID-19 condition
  • Persistent PCCFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Statistical analysis
  • Population StabilityFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Changes over Time (PCC cohort 2021 until 2024)
  • Follow-up CohortFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics second follow-up survey (March–September 2024)
  • Study LimitationsFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Strengths and limitations
  • Statistical AnalysisFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Statistical analysis
  • Participant RecontactFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Follow-up survey (phase II)
PCC Transitions | Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports | Bifalgorithm | Bifalgorithm